Tiger Buford predicts Medtronic will spin out its Spine division once IPO markets improve. The Spine business has lost market share for two decades despite acquisitions like Titus and Titan Spine, dragging down margins on more profitable segments like neurostimulation.
Chapters
And I think when the IPO market gets a little stronger, I think we're gonna see Medtronic get rid of spine. And I, I just, I just feel that's coming. Spine's gotten so hard and Medtronic's been bleeding market share for 20 years. And they, they just can't figure it out. What are they not getting? Well, they don't know how to do product development anymore. They don't know how to innovate. So they have to buy, they just buy companies. They buy Titus. You know, but that's not even working anymore. Titan Spine, they buy things like that and they plug it into their distribution and they're still flat. Yeah. I think it's hurting the margins of their other business. You know, neurostimulation and things are really good.
Wouldn't be too surprising, right? I mean, you know, they, they at first tried to dabble into, you know, total needs and, you know, they dropped that like a hot potato a few years ago.